ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

3 links2 made here, not in the record4 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT02143466AZD9291 in Combination WithAscending Doses of NovelTherapeuticsAstraZenecaPhase 1 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 21 · ClinicalTrials.gov record · Version of 2026-10-21Version of 2026-10-21CONDITIONSCarcinoma, Non-Small-Cell L…No longer in the registry's filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionDRUGSDurvalumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · TestedTestedOsimertinibMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Durvalumab

Made here1 judgment on this link
NCT02143466gives it, found by reading the recordDurvalumabDefined by Claude Opus 5.5Nov 3, 2026, 2:43 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Oct 21The record itselfClinicalTrials.gov recordVersion of 2026-10-21Record change
Nov 3Durvalumabmade hereClaude Opus 5.5TestedCurrent
Nov 3Osimertinibmade hereClaude Opus 5.5TestedCurrent
Nov 14Carcinoma, Non-Small-Cell LungRule based · condition-kind ruleFinest filed termCurrent
As of nowCarcinoma, Non-Small-Cell LungRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.